Integrated platforms spanning surgical robotics, clinical‑grade device manufacturing, and applied biotechnology. Our biomedical engineering programs cover gene therapy (CRISPR), tissue engineering, artificial organs, precision medicine, and nanomedicine—delivered under rigorous quality and regulatory frameworks.
Capabilities
- Robotic surgery systems
- Medical device production
- Biotechnology solutions
- Regulatory and clinical validation
- Sterilization and packaging engineering
- Post‑market surveillance analytics
- Gene therapy and CRISPR
- Tissue engineering and artificial organs
- Personalized medicine and companion diagnostics
- Nanomedicine delivery systems
Programs
- Minimally invasive platforms
- Biotech toolchains
- Quality and sterilization
- Human factors and usability labs
- Regulatory submissions (FDA/CE)
- Tissue scaffolds and biocompatibility
- Vector design and process development
- Companion diagnostics and clinical workflows
- UDI & traceability data pipelines
- Clinical data platforms and registries
Key Technologies
Frequently Asked Questions
Do you support contract design and manufacturing?
Yes. We provide design transfer, process validation, and full‑stack manufacturing with rigorous quality systems and applicable regulatory pathways.
What clinical areas do you cover?
Cardiovascular, neurovascular, orthopedics, endovascular, minimally invasive surgery, regenerative medicine, and precision therapeutics.
How do you manage regulatory pathways?
We implement design controls, risk management, biocompatibility evaluations, and clinical evidence strategies aligned to applicable US/EU regulations.
Do you provide sterilization and packaging validation?
We support EO, steam, and gamma validation activities along with packaging integrity and distribution testing as part of release readiness plans.
Ready to Collaborate?
Explore partnership opportunities or learn more about our Advanced Medical Technologies capabilities.